CUE BIOPHARMA INC

CUENASDAQ

🏆 #3129 by market capEarnings Aug 18US Equity

$716.09▲ $42.68 (+5.96%)

Simulated price

1h—

24h▲ 6.0%

7d—

14d—

30d—

1y—

🏦Market Cap

$110M

Small Cap

📈Revenue Growth (YoY)

+309.6%

High Growth

📊Gross Margin

—

💵FCF Margin

—

⚖️P/S Ratio

3.2x

Fair

Otter Score

65

Fair

Earnings

Q2 · 2026Reported 2026-05-14

Earnings Per Share

Actual

-1.08

Expected

-3.30

beat

+67.30%

YoY −535.30%

Revenue

Actual

$5.69M

Expected

$2.50M

beat

+127.40%

YoY +1250.60%

Consensus estimates

Recent quarters

Q2 2026

-1.08

beat

Q1 2026

0.30

beat

Q4 2025

-0.07

beat

Q3 2025

-0.09

beat